Literature DB >> 18671644

Proton magnetic resonance spectroscopy in pituitary macroadenomas: preliminary results.

Andreas Stadlbauer1, Michael Buchfelder, Christopher Nimsky, Wolfgang Saeger, Erich Salomonowitz, Katja Pinker, Gregor Richter, Hiroyoshi Akutsu, Oliver Ganslandt.   

Abstract

OBJECT: The aim of this study was to correlate proton MR (1H-MR) spectroscopy data with histopathological and surgical findings of proliferation and hemorrhage in pituitary macroadenomas.
METHODS: Quantitative 1H-MR spectroscopy was performed on a 1.5-T unit in 37 patients with pituitary macroadenomas. A point-resolved spectroscopy sequence (TR 2000 msec, TE 135 msec) with 128 averages and chemical shift selective pulses for water suppression was used. Voxel dimensions were adapted to ensure that the volume of interest was fully located within the lesion and to obtain optimal homogeneity of the magnetic field. In addition, water-unsuppressed spectra (16 averages) were acquired from the same volume of interest for eddy current correction, absolute quantification of metabolite signals, and determination of full width at half maximum of the unsuppressed water peak (FWHM water). Metabolite concentrations of choline-containing compounds (Cho) were computed using the LCModel program and correlated with MIB-1 as a proliferative cell index from a tissue specimen.
RESULTS: In 16 patients harboring macroadenomas without hemorrhage, there was a strong positive linear correlation between metabolite concentrations of Cho and the MIB-1 proliferative cell index (R = 0.819, p < 0.001). The metabolite concentrations of Cho ranged from 1.8 to 5.2 mM, and the FWHM water was 4.4-11.7 Hz. Eleven patients had a hemorrhagic adenoma and showed no assignable metabolite concentration of Cho, and the FWHM water was 13.4-24.4 Hz. In 10 patients the size of the lesion was too small (< 20 mm in 2 directions) for the acquisition of MR spectroscopy data.
CONCLUSIONS: Quantitative 1H-MR spectroscopy provided important information on the proliferative potential and hemorrhaging of pituitary macroadenomas. These data may be useful for noninvasive structural monitoring of pituitary macroadenomas. Differences in the FWHM water could be explained by iron ions of hemosiderin, which lead to worsened homogeneity of the magnetic field.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18671644     DOI: 10.3171/JNS/2008/109/8/0306

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

Review 1.  Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis.

Authors:  Wenzhuan He; Fangxiang Chen; Brian Dalm; Patricia A Kirby; Jeremy D W Greenlee
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

Review 2.  Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.

Authors:  Amy Yao; Priti Balchandani; Raj K Shrivastava
Journal:  World Neurosurg       Date:  2017-04-28       Impact factor: 2.104

3.  Clival invasion on multi-detector CT in 390 pituitary macroadenomas: correlation with sex, subtype and rates of operative complication and recurrence.

Authors:  X Chen; J Dai; L Ai; X Ru; J Wang; S Li; G S Young
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-24       Impact factor: 3.825

4.  Imaging of the pituitary: Recent advances.

Authors:  Vikas Chaudhary; Shahina Bano
Journal:  Indian J Endocrinol Metab       Date:  2011-09

5.  Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas.

Authors:  Maurits de Vries; Pancras C W Hogendoorn; Inge Briaire-de Bruyn; Martijn J A Malessy; Andel G L van der Mey
Journal:  Virchows Arch       Date:  2012-05-04       Impact factor: 4.064

6.  Utility of 7 Tesla MRI for Preoperative Planning of Endoscopic Endonasal Surgery for Pituitary Adenomas.

Authors:  John W Rutland; Bradley N Delman; Rebecca E Feldman; Nadejda Tsankova; Hung-Mo Lin; Francesco Padormo; Raj K Shrivastava; Priti Balchandani
Journal:  J Neurol Surg B Skull Base       Date:  2019-11-21

7.  Elevated levels of circulating betahydroxybutyrate in pituitary tumor patients may differentiate prolactinomas from other immunohistochemical subtypes.

Authors:  Omkar B Ijare; Cole Holan; Jonathan Hebert; Martyn A Sharpe; David S Baskin; Kumar Pichumani
Journal:  Sci Rep       Date:  2020-01-28       Impact factor: 4.379

8.  Invagination of the Sphenoid Sinus Mucosa after Endoscopic Endonasal Transsphenoidal Approach and Its Significance.

Authors:  Do Hyun Kim; Yong-Kil Hong; Sin-Soo Jeun; Jae-Sung Park; Ki Hwan Jung; Soo Whan Kim; Jin Hee Cho; Yong Jin Park; Yun Jin Kang; Sung Won Kim
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

Review 9.  Metabolomics-A Promising Approach to Pituitary Adenomas.

Authors:  Oana Pînzariu; Bogdan Georgescu; Carmen E Georgescu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-17       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.